Antonio Passaro: A must-read for anyone interested in solid tumor cell therapy
Antonio Passaro, Medical oncologist at the European Institute of Oncology in Milan, shared a post by Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, on LinkedIn, adding:
“A must-read for anyone interested in solid tumor cell therapy! This article offers essential practical insights for optimizing TIL therapy application.
Kudos to all coauthors, and especially to my friend Marco Donia for this outstanding work!”
Quoting Marco Donia’s post:
“Art of TIL (tumor-infiltrating lymphocyte) therapy: Society for Immunotherapy of Cancer (SITC) perspective on demystifying a complex treatment
(Free Access on Journal for ImmunoTherapy of Cancer, Jan 20th 2025)
Must read for all those interested in solid tumor cell therapy
Check our practical considerations for best practices to apply TIL therapy
Thanks to all coauthors, in particular Simon Turcotte and Stephanie Goff for leading this effort!”
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Authors: Simon Turcotte, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023